JP2010528088A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010528088A5 JP2010528088A5 JP2010509817A JP2010509817A JP2010528088A5 JP 2010528088 A5 JP2010528088 A5 JP 2010528088A5 JP 2010509817 A JP2010509817 A JP 2010509817A JP 2010509817 A JP2010509817 A JP 2010509817A JP 2010528088 A5 JP2010528088 A5 JP 2010528088A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical composition
- pharmaceutically acceptable
- composition according
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 11
- 239000008194 pharmaceutical composition Substances 0.000 claims 10
- 150000003839 salts Chemical class 0.000 claims 7
- 239000002253 acid Substances 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims 2
- 239000000651 prodrug Substances 0.000 claims 2
- 229940002612 prodrug Drugs 0.000 claims 2
- 230000002194 synthesizing effect Effects 0.000 claims 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- 0 *C(Cc1cc(O)c(CN2CCCC2)cc1)=O Chemical compound *C(Cc1cc(O)c(CN2CCCC2)cc1)=O 0.000 description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93215507P | 2007-05-29 | 2007-05-29 | |
| EP07113226A EP2019101A1 (en) | 2007-07-26 | 2007-07-26 | Pyrazol[3,4-d]pyrimidin-4-one useful as Kinase Inhibitor |
| PCT/EP2008/056569 WO2008145678A1 (en) | 2007-05-29 | 2008-05-28 | Pyrazolopyrimidinone kinase inhibitor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010528088A JP2010528088A (ja) | 2010-08-19 |
| JP2010528088A5 true JP2010528088A5 (OSRAM) | 2012-03-29 |
Family
ID=38556321
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010509817A Pending JP2010528088A (ja) | 2007-05-29 | 2008-05-28 | キナーゼ阻害剤 |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US8304418B2 (OSRAM) |
| EP (2) | EP2019101A1 (OSRAM) |
| JP (1) | JP2010528088A (OSRAM) |
| KR (1) | KR20100040806A (OSRAM) |
| CN (1) | CN101765600A (OSRAM) |
| AR (1) | AR066737A1 (OSRAM) |
| AT (1) | ATE522533T1 (OSRAM) |
| AU (1) | AU2008257534A1 (OSRAM) |
| CA (1) | CA2689090A1 (OSRAM) |
| DK (1) | DK2170891T3 (OSRAM) |
| EA (1) | EA200901536A1 (OSRAM) |
| ES (1) | ES2370677T3 (OSRAM) |
| HR (1) | HRP20110768T1 (OSRAM) |
| IL (1) | IL202375A0 (OSRAM) |
| MX (1) | MX2009012832A (OSRAM) |
| SI (1) | SI2170891T1 (OSRAM) |
| TW (1) | TW200906831A (OSRAM) |
| WO (1) | WO2008145678A1 (OSRAM) |
| ZA (1) | ZA200908943B (OSRAM) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010125004A1 (en) * | 2009-04-29 | 2010-11-04 | Nerviano Medical Sciences S.R.L. | Cdk inhibitor salts |
| WO2013059634A1 (en) | 2011-10-20 | 2013-04-25 | The Regents Of The University Of California | Use of cdk9 inhibitors to reduce cartilage degradation |
| WO2015172713A1 (zh) * | 2014-05-13 | 2015-11-19 | 广东东阳光药业有限公司 | 一种中间体的制备方法 |
| JP6930913B2 (ja) | 2014-10-14 | 2021-09-01 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアＴｈｅ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃａｌｉｆｏｒｎｉａ | 炎症を阻害するためのｃｄｋ９及びｂｒｄ４阻害剤の使用法 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
| US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| US3916889A (en) * | 1973-09-28 | 1975-11-04 | Sandoz Ag | Patient ventilator apparatus |
| US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
| US4710384A (en) | 1986-07-28 | 1987-12-01 | Avner Rotman | Sustained release tablets made from microcapsules |
| EG18377A (en) | 1986-09-19 | 1993-04-30 | Lilly Co Eli | Process for preparing glycopeptide antibiotics |
| US5073543A (en) | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
| IT1229203B (it) | 1989-03-22 | 1991-07-25 | Bioresearch Spa | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. |
| US5120548A (en) | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
| US5733566A (en) | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
| US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
| EP1005870B1 (en) | 1992-11-13 | 2009-01-21 | Biogen Idec Inc. | Therapeutic application of chimeric antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| US5736137A (en) | 1992-11-13 | 1998-04-07 | Idec Pharmaceuticals Corporation | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| US5591767A (en) | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
| IT1270594B (it) | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida |
| US6559152B2 (en) * | 1998-10-13 | 2003-05-06 | Dupont Pharmaceuticals Company | 6-substituted pyrazolo[3,4-d]pyrimidin-4-ones useful as cyclin dependent kinase inhibitors |
| US6531477B1 (en) * | 1998-10-13 | 2003-03-11 | Dupont Pharmaceuticals Company | 6-substituted pyrazolo [3,4-d] pyrimidin-4-ones useful as cyclin dependent kinase inhibitors |
| DE60035337T2 (de) | 2000-05-12 | 2008-02-28 | Gpc Biotech Ag | Humane Peptide/Proteine, die das Töten von Zellen, einschliesslich lymphoider Tumorzellen, herbeiführen oder bewirken |
| IT1317975B1 (it) | 2000-06-16 | 2003-07-21 | Christian Pio Pedulla | Presa multipla volante. |
| WO2003063764A2 (en) * | 2001-07-10 | 2003-08-07 | Bristol-Myers Squibb Pharma Company | 6-SUBSTITUTED PYRAZOLO [3,4-d] PYRIMIDIN-4-ONES USEFUL AS CYCLIN DEPENDENT KINASE INHIBITORS |
| EP1446405A2 (en) * | 2001-10-15 | 2004-08-18 | GPC Biotech Inc. | Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| WO2004092139A2 (en) * | 2003-04-07 | 2004-10-28 | Gpc Biotech, Inc. | Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| US8084457B2 (en) | 2003-09-15 | 2011-12-27 | Lead Discovery Center Gmbh | Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases |
| KR101155883B1 (ko) | 2003-12-23 | 2012-06-20 | 아제닉스 유에스에이 인코포레이티드 | 사이클린 의존적 키나제 저해제, 그 조성물 및 그의 용도 |
-
2007
- 2007-07-26 EP EP07113226A patent/EP2019101A1/en not_active Withdrawn
-
2008
- 2008-05-28 AT AT08760162T patent/ATE522533T1/de active
- 2008-05-28 ES ES08760162T patent/ES2370677T3/es active Active
- 2008-05-28 US US12/602,021 patent/US8304418B2/en not_active Expired - Fee Related
- 2008-05-28 EP EP08760162A patent/EP2170891B1/en not_active Not-in-force
- 2008-05-28 AR ARP080102229A patent/AR066737A1/es unknown
- 2008-05-28 HR HR20110768T patent/HRP20110768T1/hr unknown
- 2008-05-28 SI SI200830428T patent/SI2170891T1/sl unknown
- 2008-05-28 EA EA200901536A patent/EA200901536A1/ru unknown
- 2008-05-28 CA CA002689090A patent/CA2689090A1/en not_active Abandoned
- 2008-05-28 AU AU2008257534A patent/AU2008257534A1/en not_active Abandoned
- 2008-05-28 CN CN200880100285A patent/CN101765600A/zh active Pending
- 2008-05-28 JP JP2010509817A patent/JP2010528088A/ja active Pending
- 2008-05-28 KR KR1020097027211A patent/KR20100040806A/ko not_active Withdrawn
- 2008-05-28 DK DK08760162.1T patent/DK2170891T3/da active
- 2008-05-28 WO PCT/EP2008/056569 patent/WO2008145678A1/en not_active Ceased
- 2008-05-28 MX MX2009012832A patent/MX2009012832A/es not_active Application Discontinuation
- 2008-05-29 TW TW097119933A patent/TW200906831A/zh unknown
-
2009
- 2009-11-26 IL IL202375A patent/IL202375A0/en unknown
- 2009-12-15 ZA ZA200908943A patent/ZA200908943B/xx unknown
-
2012
- 2012-10-09 US US13/647,572 patent/US20130035349A1/en not_active Abandoned